A. Patrick

发表

Identification of individuals with CKD from Medicare claims data: a validation study.

J. Avorn, S. Schneeweiss, W. Winkelmayer, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The costs and benefits of enhanced depression care to employers.

R. Kessler, J. Avorn, Philip S. Wang, 2006, Archives of general psychiatry.

Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians

M. Alan Brookhart, W. Shrank, A. Patrick, 2011, Journal of General Internal Medicine.

A tool for assessing the feasibility of comparative effectiveness research

Richard Platt, Sebastian Schneeweiss, Véronique L. Roger, 2013 .

Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.

J. Avorn, S. Schneeweiss, Philip S. Wang, 2007, Journal of clinical psychopharmacology.

The increasing prevalence of atrial fibrillation among hemodialysis patients.

W. Winkelmayer, M. Brookhart, A. Patrick, 2011, Journal of the American Society of Nephrology : JASN.

Antidepressants and Fracture Risk in Older Adults: A Comparative Safety Analysis

J. Gagne, H. Mogun, A. Patrick, 2011, Clinical pharmacology and therapeutics.

Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.

S. Schneeweiss, A. Patrick, M. Maclure, 2008, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits.

S. Schneeweiss, W. Shrank, A. Patrick, 2009, Health affairs.

The Effect of Transitioning to Medicare Part D Drug Coverage in Seniors Dually Eligible for Medicare and Medicaid

S. Schneeweiss, W. Shrank, A. Patrick, 2008, Journal of the American Geriatrics Society.

Can Improved Prescription Medication Labeling Influence Adherence to Chronic Medications? An Evaluation of the Target Pharmacy Label

J. Avorn, S. Schneeweiss, M. Brookhart, 2009, Journal of General Internal Medicine.

Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation

T. Brennan, J. Avorn, W. Shrank, 2013, Circulation. Cardiovascular quality and outcomes.

Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.

J. Avorn, S. Schneeweiss, Philip S. Wang, 2010, The journal of mental health policy and economics.

The impact of cost sharing on antidepressant use among older adults in British Columbia.

J. Avorn, S. Schneeweiss, Philip S. Wang, 2008, Psychiatric services.

Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.

J. Katz, A. Patrick, D. Solomon, 2006, Arthritis and rheumatism.

An Evaluation of the Relationship Between the Implementation of a Newly Designed Prescription Drug Label at Target Pharmacies and Health Outcomes

J. Avorn, S. Schneeweiss, M. Wolf, 2009, Medical care.

Validating studies of adherence through the use of control outcomes and exposures.

M. Brookhart, W. Shrank, A. Patrick, 2010, American journal of hypertension.

Osteoporosis Telephonic Intervention to Improve Medication Adherence (OPTIMA): A Large Pragmatic Randomized Controlled Trial

J. Avorn, M. Brookhart, J. Lii, 2014 .

Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use.

M Alan Brookhart, Sebastian Schneeweiss, Daniel H Solomon, 2007, Archives of internal medicine.

Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study

A. Patrick, N. Gatto, P. Jónsson, 2022, BMJ Open.

Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect.

J. Avorn, M. Brookhart, W. Shrank, 2007, American journal of epidemiology.

Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.

Jaime Caro, J. Caro, A. Patrick, 2003, Clinical therapeutics.

The Potential Economic Benefits of Improved Postfracture Care: A Cost‐Effectiveness Analysis of a Fracture Liaison Service in the US Health‐Care System

E. Losina, A. Patrick, D. Solomon, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The economics of improving medication adherence in osteoporosis: validation and application of a simulation model.

E. Losina, A. Patrick, D. Solomon, 2011, The Journal of clinical endocrinology and metabolism.

Estimation using all available covariate information versus a fixed look‐back window for dichotomous covariates

J. Gagne, K. Huybrechts, K. Rothman, 2013, Pharmacoepidemiology and drug safety.

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death.

J. Avorn, S. Schneeweiss, A. Patrick, 2010, Journal of the American Medical Association (JAMA).

The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration

M Alan Brookhart, Til Stürmer, Sebastian Schneeweiss, 2011, Pharmacoepidemiology and drug safety.

Identification of hospitalizations for intentional self‐harm when E‐codes are incompletely recorded

Sebastian Schneeweiss, S. Schneeweiss, Philip S. Wang, 2010, Pharmacoepidemiology and drug safety.

Comparative Safety of Antidepressant Agents for Children and Adolescents Regarding Suicidal Acts

Sebastian Schneeweiss, Daniel H Solomon, S. Schneeweiss, 2010, Pediatrics.

Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison With Randomized Trial Results

J. Avorn, S. Schneeweiss, K. Rothman, 2007, Medical care.

Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

JA Rassen, J. Rassen, A. Patrick, 2016, Clinical pharmacology and therapeutics.

Evaluation of Long-Term Anticoagulation Therapy [RELY]), apixaban (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation [ARISTOTLE]), and rivaroxaban (Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Strok

J. Avorn, J. Gagne, S. Schneeweiss, 2012 .

Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation

Jerry Avorn, Niteesh K. Choudhry, J. Avorn, 2009, Circulation. Cardiovascular quality and outcomes.

Comparative Efficacy and Safety of New Oral Anticoagulants in Patients With Atrial Fibrillation

Sebastian Schneeweiss, Joshua J Gagne, Jerry Avorn, 2012, Circulation. Cardiovascular quality and outcomes.

Statin Adherence and Risk of Accidents: A Cautionary Tale

James M Wright, M Alan Brookhart, Robert J Glynn, 2009, Circulation.

Cost of managing complications resulting from type 2 diabetes mellitus in Canada

J. Caro, A. Patrick, J. O'brien, 2003, BMC health services research.

When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study

J. Smoller, Philip S. Wang, R. Perlis, 2009, Neuropsychopharmacology.

Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post–Myocardial Infarction Medicare Beneficiaries

William H Shrank, Jerry Avorn, E. Antman, 2008, Circulation.

Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia

J. Avorn, W. Winkelmayer, M. Fischer, 2012, PharmacoEconomics.

Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases

Jeremy A Rassen, Sebastian Schneeweiss, J. Rassen, 2018, Clinical epidemiology.

Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples

J. Avorn, J. Rassen, J. Gagne, 2012, Drug Safety.

Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction.

T. Brennan, E. Antman, J. Avorn, 2012, Health services research.

Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

S. Schneeweiss, A. Patrick, D. Bartels, 2014, Diabetologia.

Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.

W. Winkelmayer, M. Brookhart, A. Patrick, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Using claims data to predict dependency in activities of daily living as a proxy for frailty

M. Brookhart, T. Stürmer, A. Patrick, 2015, Pharmacoepidemiology and drug safety.

Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis.

W. Winkelmayer, A. Patrick, N. Choudhry, 2012, Journal of nephrology.

Addressing Limitations in Observational Studies of the Association Between Glucose-Lowering Medications and All-Cause Mortality: A Review

S. Schneeweiss, A. Patrick, D. Bartels, 2015, Drug Safety.

Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance.

J. Avorn, J. Katz, M. Brookhart, 2007, The American journal of medicine.

Interactive voice response telephone calls to enhance bone mineral density testing.

T. Weiss, A. Patrick, D. Solomon, 2006, The American journal of managed care.

Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review

J. Avorn, J. Katz, W. Shrank, 2009, Osteoporosis International.

Psychotropic medication use for behavioral symptoms of dementia

S. Schneeweiss, Philip S. Wang, M. Brookhart, 2006, Current neurology and neuroscience reports.

Adherence to Statin Therapy Under Drug Cost Sharing in Patients With and Without Acute Myocardial Infarction: A Population-Based Natural Experiment

S. Schneeweiss, R. Glynn, A. Patrick, 2007, Circulation.

The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels.

Robert J Glynn, Jerry Avorn, J. Avorn, 2011, Journal of the American College of Cardiology.

Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction.

S. Schneeweiss, R. Glynn, A. Patrick, 2007, The American journal of managed care.

Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors

J. Katz, M. Brookhart, A. Patrick, 2011, Osteoporosis International.

Near-Real-Time Monitoring of New Drugs: An Application Comparing Prasugrel Versus Clopidogrel

Jun Liu, Jeremy A Rassen, Sebastian Schneeweiss, 2014, Drug Safety.

Suboptimal Antidepressant Use in the Elderly

J. Avorn, S. Schneeweiss, R. Glynn, 2005, Journal of clinical psychopharmacology.

Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial.

J. Avorn, J. Katz, M. Brookhart, 2012, Archives of internal medicine.

Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.

S. Schneeweiss, Philip S. Wang, A. Patrick, 2010, Archives of general psychiatry.

The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults.

J. Avorn, R. Glynn, M. Brookhart, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost of managing an episode of relapse in multiple sclerosis in the United States

J. Caro, A. Patrick, A. Ward, 2003, BMC health services research.

Health Advisories and Patterns of Patient Monitoring Among New Users of Antidepressant Medications

J. Gagne, S. Schneeweiss, Philip S. Wang, 2009, Journal of clinical psychopharmacology.

A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial

J. Avorn, J. Katz, M. Brookhart, 2009, Osteoporosis International.

Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

S. Hernández-Díaz, A. Patrick, S. Setoguchi, 2012, American journal of epidemiology.

Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot

A. Patrick, J. Carlson, Yilin Chen, 2022, International Journal of Technology Assessment in Health Care.

The complex relation between bisphosphonate adherence and fracture reduction.

M. Brookhart, H. Mogun, E. Losina, 2010, The Journal of clinical endocrinology and metabolism.

Sequential Value-of-Information Assessment for Prospective Drug Safety Monitoring Using Claims Databases

M. Weinstein, S. Schneeweiss, R. Glynn, 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

Trends in Insulin Initiation and Treatment Intensification Among Patients with Type 2 Diabetes

J. Avorn, M. Fischer, W. Shrank, 2014, Journal of General Internal Medicine.

KEY LEARNINGS FROM ICER'S REAL WORLD EVIDENCE REASSESSMENT PILOT.

A. Patrick, J. Carlson, L. Bloudek, 2022, International journal of technology assessment in health care.

Health Care Services in Resource Use Profiles Low Intensity Episode # Initial Contact : • Usual care

J. Caro, A. Patrick, A. Ward, 2015 .

Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction.

T. Brennan, E. Antman, J. Avorn, 2012, Health services research.

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death.

J. Avorn, S. Schneeweiss, A. Patrick, 2010, JAMA.

American Journal of Epidemiology Original Contribution Elevated Risk of Preeclampsia in Pregnant Women with Depression: Depression or Antidepressants?

A. Patrick, S. Setoguchi, A. Margulis, 2022 .